North America Forensic Genomics Market Size, Share & Industry Trends Analysis Report By Application (Criminal Testing, Paternity & Familial Testing), By Product (Kits & Consumables, Analyzers & Sequencers and Software), By Method, By Country and Growth Forecast, 2022 - 2028

The North America Forensic Genomics Market should witness market growth of 13.9% CAGR during the forecast period (2022-2028).

The first draft of the human genome sequence was produced by the ten-year, multibillion-dollar Human Genome Project (HGP). This draft genome marked the start of a breakthrough in the biomedical sciences, with a concentration on studies into human evolution as well as medical prognostics, diagnostics, and medication therapies.

The usefulness of being able to sequence a full human genome has exceeded all aspirations in the domain of forensic human identification. Since the first human genome sequence was completed two decades ago, desktop massively parallel sequencing (MPS) machines have made sequencing technology more accessible.

The once-impossible aim of sequencing the complete human genome is feasible owing to MPS's improving user-friendliness and robustness, as well as the sharp decline in sequencing times and costs. With these capabilities, whole genome sequencing from biological evidence discovered at a scene of the crime is now a practical endeavor for solving crimes and generating investigative leads.

Numerous forensic science fields, including genome sequencing, are evolving in the US. To aid in criminal investigations, new methods are being tested, developed, and put into use. Investigators frequently encounter problems with the veracity and accuracy of both modern and traditional approaches. Disaster victim identification, criminal casework, missing person identification, DNA database administration, mtDNA analysis, and STR and SNP sequencing are a few of the uses.

The US market dominated the North America Forensic Genomics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $285.2 Million by 2028. The Canada market is poised to grow at a CAGR of 16.5% during (2022-2028). Additionally, The Mexico market would showcase a CAGR of 15.4% during (2022-2028).

Based on Application, the market is segmented into Criminal Testing, Paternity & Familial Testing and Others. Based on Product, the market is segmented into Kits & Consumables, Analyzers & Sequencers and Software. Based on Method, the market is segmented into Capillary Electrophoresis, Next-generation Sequencing and PCR Amplification. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Eurofins Scientific Group (Eurofins Discovery), Gene by Gene, Ltd., Verogen, Inc., Agilent Technologies, Inc., Illumina, Inc., Neogen Corporation, and Thermo Fisher Scientific, Inc.

Scope of the Study

By Application

• Criminal Testing
• Paternity & Familial Testing
• Others

By Product

• Kits & Consumables
• Analyzers & Sequencers
• Software

By Method

• Capillary Electrophoresis
• Next-generation Sequencing
• PCR Amplification

By Country

• US
• Canada
• Mexico
• Rest of North America

Key Market Players

List of Companies Profiled in the Report:

• General Electric (GE) Co. (GE Healthcare)
• Eurofins Scientific Group (Eurofins Discovery)
• Gene by Gene, Ltd.
• Verogen, Inc.
• Agilent Technologies, Inc.
• Illumina, Inc.
• Neogen Corporation
• Thermo Fisher Scientific, Inc.

Unique Offerings

• Exhaustive coverage
• The highest number of Market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free